Live feed07:00:00·12mPRReleasevia QuantisnowLigand Acquires Royalty and Milestone Interest in Santen’s Ryjunea® from Sydnexis for $23 MillionByQuantisnow·Wall Street's wire, on your screen.LGND· Ligand Pharmaceuticals IncorporatedHealth Care
